Sodium Ioxaglate
| Code | Size | Price |
|---|
| TAR-T28826-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Sodium Ioxaglate is used as a contrast agent.
CAS:
67992-58-9
Formula:
C25H21I6N4NaO8
Molecular Weight:
1289.88
Purity:
0.98
SMILES:
[Na+].CCC(=O)c1c(I)c(N(C)C(C)=O)c(I)c(C(=O)NCC(=O)Nc2c(I)c(C([O-])=O)c(I)c(C(=O)NCCO)c2I)c1I
References
1. Conrozier T, Patarin J, Mathieu P, Rinaudo M. Steroids, lidocain and ioxaglic acid modify the viscosity of hyaluronic acid: in vitro study and clinical implications. Springerplus. 2016 Feb 24;5:170. doi: 10.1186/s40064-016-1762-z. eCollection 2016. PubMed PMID: 27026867; PubMed Central PMCID: PMC4766165.
2. Vishwanath S, Baroody FM, Chaaban MR, deTineo M, Lasser KH, Lasser EC, Naclerio RM. Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen. J Allergy Clin Immunol. 2011 Jul;128(1):219-21. doi: 10.1016/j.jaci.2011.02.024. Epub 2011 Mar 17. PubMed PMID: 21414657.
3. Obermann WR, Bloem JL, Hermans J. Knee arthrography: comparison of iotrolan and ioxaglate sodium meglumine. Radiology. 1989 Oct;173(1):197-201. PubMed PMID: 2781008.
4. Obermann WR, Kieft GJ. Knee arthrography: a comparison of iohexol, ioxaglate sodium meglumine, and metrizoate. Radiology. 1987 Mar;162(3):729-33. PubMed PMID: 3544035.